Avalo Therapeutics
AVTX
AVTX
31 hedge funds and large institutions have $135M invested in Avalo Therapeutics in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+11
Holders Change %
+55%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
13
Increased
8
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$3.5M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$1.97M |
| 3 |
AC
Armistice Capital
New York
|
+$1.03M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$793K |
| 5 |
Millennium Management
New York
|
+$777K |
Top Sellers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$1.11M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$203K |
| 3 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$118K |
| 4 |
PC
PA Capital
Richmond,
Virginia
|
-$54K |
| 5 |
BlackRock
New York
|
-$34K |
